mtm’s P16/Ki-67 Dual Immuno-Staining Identifies High-Grade Cervical Disease In ASC-US And LSIL With High Sensitivity And Specificity

Wednesday, March 30th, 2011

mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, today announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of ...

[-2]Proenzyme Prostate Specific Antigen Is More Accurate Than Total And Free Prostate Specific Antigen In Differentiating

Sunday, July 25th, 2010

UroToday.com - Prostate Specific Antigen (PSA), the primary means of diagnosing prostate cancer in the modern era, lacks specificity in differentiating benign from malignant disease. Thus clinical decisions based on PSA may lead to unnecessary biopsies in some while overlooking biopsies in others. p2PSA has emerged from studies ...

PCA3, A Urine Test For Prostate Cancer, Shows Increased Specificity Compared To Prostate-Specific Antigen Test

Wednesday, June 2nd, 2010

A new urine test showed significant specificity when used to detect prostate cancer, according to a new multi-institution study from researchers in Colorado, Pennsylvania, New York and Virginia. Data on the new PCA3 urine test were presented during the 105th Annual Scientific Meeting of the American Urological Association (AUA). David ...

A New Pediatric Study Finds Seegene’s Seeplex(R) Assay To Be ‘Excellent’ As A Diagnostic Test For Detecting Respiratory Viruses

Thursday, May 27th, 2010

A recent research study compared the effectiveness of three commercial multiplex respiratory virus polymerase chain reaction (PCR) assays and conventional assays for detection of respiratory viruses and swine-origin 2009 A (H1N1) influenza virus in children. Results from research conducted at The Hospital for Sick Children (SickKids) demonstrated that Seeplex® diagnostic ...

Chronix To Present Data At ASCO That Could Revolutionize The Diagnostic Paradigm For Cancer

Tuesday, May 25th, 2010

Chronix Biomedical today reported a summary of data supporting the utility of its serum DNA blood tests for the early and accurate detection of breast cancer and prostate cancer. The unique testing algorithms developed by Chronix detected and correctly identified DNA fragments in the blood from dying (apoptotic) cancer cells ...